Downregulation of NOX4 expression by RNA interference or treatment with NOX4 inhibitors such as schisandrin B also notably decreased ROS production in FLT3-ITD-mutated AML, and reduced both in vitro and in vivo FLT3-ITD-driven signaling and cell transformation [33]. This evidence concerns the gene FLT3 and acute myeloid leukemia.